Abstract: This disclosure relates generally to the field of Electroencephalogram (EEG) classification, and, more particularly, to method and system for EEG motor imagery classification. Existing deep learning works employ the sensor-space for EEG graph representations wherein the channels of the EEG are considered as nodes and connection between the nodes are either predefined or are based on certain heuristics. However, these representations are ineffective and fail to accurately capture the underlying brain's functional networks. Embodiments of present disclosure provide a method of training a weighted adjacency matrix and a Graph Neural Network (GNN) to accurately represent the EEG signals. The method also trains a graph, a node, and an edge classifier to perform graph classification (i.e. motor imagery classification), node and edge classification. Thus, representations generated by the GNN can be additionally used for node and edge classification unlike state of the art methods.

Abstract: Systems and methods for error detection within a multi-session collaborative environment. One method includes receiving, from a first client application session associated with a first user, a first diagnostic log, including an error message. The method includes determining a second client application session associated with a second user in a collaboration session with the first client session, and triggering, in the second client application session, an artificial error condition based on the error message. The method includes, receiving, from the second client application session, a second diagnostic log. The method includes tagging the first and second diagnostic logs with a session identifier indicative of the collaboration session, and transmitting the first and second diagnostic logs to a collaborative environment administrator. The method includes transmitting a notification based on the error to at least one of the first client application session and the second client application session.

Abstract: Systems and methods for error detection within a multi-session collaborative environment. One method includes receiving, from a first client application session associated with a first user, a first diagnostic log, including an error message. The method includes determining a second client application session associated with a second user in a collaboration session with the first client session, and triggering, in the second client application session, an artificial error condition based on the error message. The method includes, receiving, from the second client application session, a second diagnostic log. The method includes tagging the first and second diagnostic logs with a session identifier indicative of the collaboration session, and transmitting the first and second diagnostic logs to a collaborative environment administrator. The method includes transmitting a notification based on the error to at least one of the first client application session and the second client application session.

Abstract: A dynamic load balancing system is described that determines the load of resources in a hosted environment dynamically by monitoring the usage of resources by each customer and determines the number of customers hosted by a server based on the actual resources used. The system receives a performance threshold that indicates when a server is too heavily loaded and monitors the resource usage by each customer. When the load of an overloaded server in the hosted environment exceeds the received performance threshold, the system selects a source customer currently hosted by the overloaded server to move to another server.

Abstract: This inventive subject matter relates to novel transitional metal complexes of Quinoxalines, methods for making such compounds, and methods for using such compounds for treating diseases and disorders mediated by kinase activity. The present invention relates to new substituted Quinoxaline compounds, their tautomers, stereoisomers, polymorphs, esters, metabolites, and prodrugs, to the pharmaceutically acceptable salts of the compounds, tautomers, stereoisomers, polymorphs, esters, metabolites, and prodrugs, to compositions of any of the aforementioned embodiments together with pharmaceutically acceptable carriers, and to uses of any of the aforementioned embodiments, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cancer.

Abstract: A dynamic load balancing system is described that determines the load of resources in a hosted environment dynamically by monitoring the usage of resources by each customer and determines the number of customers hosted by a server based on the actual resources used. The system receives a performance threshold that indicates when a server is too heavily loaded and monitors the resource usage by each customer. When the load of an overloaded server in the hosted environment exceeds the received performance threshold, the system selects a source customer currently hosted by the overloaded server to move to another server.

Abstract: A novel edible polymer based film dosage form manufactured using natural, synthetic, semisynthetic, pharmaceutically acceptable polymers addressing the issues of swallowing difficulties (Dysphagia and Dynaphagia), of tablet or capsule dosage forms and handling and storage difficulties associated with liquid dosage forms, that also includes materials such as emulsifying agents, suspending agents, buffering agents, effervescence agents, colorants, flavorants, sweetners and specified amounts of bioactive agents preferably having perforations in the body of the dosage form enabling it to disperse/dissolve rapidly upon application by the subject. A flexible film dosage form to accommodate higher drug loads without compromising the fast dispersing/dissolving characteristics is presented. The perforated film system is enabled to be used in various applications such as oral, mucosal and external environments.

Abstract: A novel edible polymer based film dosage form manufactured using natural, synthetic, semisynthetic, pharmaceutically acceptable polymers addressing the issues of swallowing difficulties (Dysphagia and Dynaphagia), of tablet or capsule dosage forms and handling and storage difficulties associated with liquid dosage forms, that also includes materials such as emulsifying agents, suspending agents, buffering agents, effervescence agents, colorants, flavorants, sweeteners and specified amounts of bioactive agents, for erectile dysfunction. A flexible film dosage form containing sildenafil citrate, tadalafil or Vardenafil is presented. The film system is enabled to be used in various applications such as oral, mucosal and external environments.